Main > NEPHROLOGY > UK. A. CKD>Treat.>SGLT2 Inhibitor

---

UK. A. CKD>Treat.>SGLT2 Inhibitor's subsections
(*) CN Approval Date: 2022. 09.05
(*) USA Approval Date: 2021. 04.30
Company
Generic Name: dapagliflozin
RTM
RTM Web-Site
SGLT: Sodium-GLucose coTransporter
USA Patent Numbers

UK. A. CKD>Treat.>SGLT2 Inhibitor's products
This section has no products